SCHEMBL5461009

SCHEMBL5461009

CCc1c(F)c(C(=O)O)cc(F)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.43
▸ NFE2L2 Q16236 1/20 0.43
▸ MRGPRX4 Q96LA9 2/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ KDM5A P29375 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ KDM5B Q9UGL1 1/20 0.34
▸ RARB P10826 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506073 0.84 KEAP1 (0.39) KEAP1NFE2L2RARBKDM4EGABRP
SCHEMBL9723102 0.83 CYP3A4 (0.46) KEAP1NFE2L2MRGPRX4KDM4EALDH1A1
SCHEMBL8578094 0.80 GABRP (0.40) KEAP1NFE2L2RARBKDM4EGABRP
SCHEMBL22972614 0.77 KEAP1 (0.52) KEAP1NFE2L2KDM4AKDM5AKDM4C
SCHEMBL2477663 0.77 KEAP1 (0.41) KEAP1NFE2L2MRGPRX4KDM4AKDM5A
SCHEMBL3337887 0.74 ALDH1A1 (0.41) KEAP1NFE2L2MRGPRX4RARBKDM4E
SCHEMBL29376622 0.74 KEAP1 (0.52) KEAP1NFE2L2KDM4EALDH1A1SMN1; SMN2
SCHEMBL2434231 0.74 KEAP1 (0.52) KEAP1NFE2L2KDM4EALDH1A1SMN1; SMN2
SCHEMBL1541651 0.73 CES2 (0.41) RARBKDM4EALDH1A1MEN1KMT2A
SCHEMBL26497713 0.73 KEAP1 (0.47) KEAP1NFE2L2KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021634-A1 SYNTHESIS OF THERAPEUTIC DIPHENYL ETHERS PFIZER INC 2007-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021634-A1 SYNTHESIS OF THERAPEUTIC DIPHENYL ETHERS DHFR, CYP2F1, EPOR KEAP1 1129/4885NFE2L2 543/4885MRGPRX4 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback